The ability of Costunolide to significantly diminish tumor volume (Figure 5a) and weight (Supplementary Figure 3A) was accompanied by downregulation of telomerase activity (Figure 5b), increase in ROS level (Figure 5c), and elevated caspase 3/8 activity (Supplementary Figure 3B and C). Here, CASP3 is linked to neoplasm.